Myomo

Myomo Announces Technology Licensing Program for International Markets

Ziad2022-11-25T14:03:26-05:00 Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has launched a business development program to bring its proprietary MyoPro orthotic product line to a greater number of country markets outside of the United States. Read more >>

Myomo®’s International Distribution Partners Launch Patient Screening Days

Ziad2022-11-25T14:03:27-05:00 Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces that its international distributors in six countries are adopting the marketing model used successfully in the U.S. of introducing the MyoPro® powered orthosis to candidates through screening days. Read more >>

Myomo scales up production, training for MyoPro device for upper-body mobility

Ziad2022-11-25T14:03:38-05:00 From perception and analysis to actuation, many robotics technologies have applications in healthcare, particularly in prosthetics and assistive systems. Myomo Inc.’s MyoPro is a wearable brace that uses sensors and algorithms to restore mobility to users. Read more >>

Myomo® Announces New Distribution Agreement for Australia / New Zealand

Ziad2022-11-25T14:03:38-05:00 Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with NeuroMuscular Orthotics Pty Ltd (NMO) with the goal of offering MyoPro across Australia and New Zealand. Read more >>

Myomo inks Italian sales deal

Ziad2022-11-25T14:03:38-05:00 Myomo recently announced that it has signed a sales and service agreement with Progettiamo Autonomia Robotics (PAR) to market the MyoPro in Italy. Read more >>

Myomo® Announces New Sales and Service Agreement for Italy

Ziad2022-11-25T14:03:39-05:00 Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has signed an agreement with Progettiamo Autonomia Robotics (PAR) with the goal of offering MyoPro in Italy. Read more >>

Myomo closes $6m funding round

Ziad2022-11-25T14:03:39-05:00 Myomo said today that it closed a $6.4 million round of financing. The Cambridge, Mass.-based wearable medical robotics company said that it floated approximately four million shares of its common stock at $1.40 per share for gross proceeds of approximately $5.5 million. Read more >>

Myomo Announces CFO Succession

Ziad2022-11-25T14:03:39-05:00 Myomo Inc., a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, 2019. Read more >>

Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference

Ziad2022-11-25T14:03:39-05:00Myomo, Inc., a wearable medical robotics company, today announced that it will be presenting at NobleCon15 - Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:30 AM EST - Studio 3. Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer Ralph A. Goldwasser will be presenting, as well as meeting with investors. Read more >>

Myomo Announces First Adolescent Patients to be Fitted with MyoPro

Ziad2022-11-25T14:04:53-05:00Robotic lightweight wearable device empowers young adults with arm paralysis to live independently, while also reducing healthcare costs. Read more >>